Illness	Number of cases
Recurrent depressive disorder - Major depressive disorder recurrent moderate (F33.1)	40
Recurrent depressive disorder - Major depressive disorder recurrent severe without psychotic features (F33.2)	25
Schizophrenia - Paranoid schizophrenia (F20.0)	20
Depressive episode - Major depressive disorder single episode moderate (F32.1)	19
Depressive episode - Major depressive disorder single episode severe without psychotic features (F32.2)	9
Schizoaffective disorders - Schizoaffective disorder depressive type (F25.1)	7
Hyperkinetic disorders - Attention-deficit hyperactivity disorder predominantly inattentive type (F90.0)	4
Personality and behavioural disorders due to brain disease damage and dysfunction - Personality change due to known physiological condition (F07.0)	not specified
Mental and behavioural disorders due to use of cannabinoids (F12.1)	not specified
Mental and behavioural disorders due to use of cannabinoids (F12.2)	not specified

Top 10 treatments

Treatment	Number
(9-649.0)	289
Standard treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-607)	243
(9-649.11)	204
(9-649.31)	186
Complex psychotherapeutic treatment for mental and psychosomatic disorders and behavioral disorders in adults (9-626)	158
(9-649.40)	66
(9-649.10)	53
(9-649.32)	41
(9-649.41)	36
(9-649.12)	31

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2960

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
3	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
2	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
2	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility